Mary Naufal, PharmD, MS, BCOP, discusses innovative use of isatuximab for red cell aplasia post-stem cell transplant, highlighting its potential in clinical trials.
Mary Naufal, PharmD, MS, BCOP
Advertisement
Articles by Mary Naufal, PharmD, MS, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Improved Outcomes in NDTE Multiple Myeloma With Belantamab Mafodotin Plus VRd Following 2 Years of Maintenance
2
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Psoriatic Arthritis
3
FDA Approves 10% IVIG Formulation For Adults With Primary Humoral Immunodeficiency
4
Annual Pharmacy Technician Convention Brings Educational Opportunities, Leadership Development
5
